scholarly article | Q13442814 |
P953 | full work available at URL | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6353643/?tool=EBI |
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6353643/pdf/?tool=EBI | ||
https://europepmc.org/articles/PMC2729119 | ||
https://europepmc.org/articles/PMC2729119?pdf=render | ||
P932 | PMC publication ID | 2729119 |
P698 | PubMed publication ID | 6353643 |
P50 | author | Thomas E. Starzl | Q1248240 |
P2093 | author name string | T. R. Hakala | |
S. Iwatsuki | |||
B. W. Shaw | |||
J. T. Rosenthal | |||
P2860 | cites work | Cyclosporin A in patients receiving renal allografts from cadaver donors | Q34347891 |
Steps in immunosuppression for renal transplantation | Q34497811 | ||
Proceedings: The outcome of kidney retransplantation | Q34561550 | ||
Cyclosporin A in cadaveric organ transplantation | Q34778331 | ||
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients | Q37164604 | ||
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. | Q37175908 | ||
The use of cyclosporin A and prednisone in cadaver kidney transplantation | Q37305573 | ||
Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids | Q37311411 | ||
Kaposi’s sarcoma in a patient after renal transplantation | Q38928068 | ||
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers | Q39574059 | ||
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization | Q40776601 | ||
Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: An initial report | Q40892188 | ||
100 second renal allografts from a single transplantation institution | Q41041999 | ||
Tumor incidence in human allograft recipients | Q41056894 | ||
Ten Year Experience with Renal Transplantation in Juvenile Onset Diabetics | Q41103977 | ||
Cadaveric Renal Transplantation With Cyclosporin-A and Steroids. | Q41105613 | ||
Cadaver donor renal transplantation by centers of the Southeastern Organ Procurement Foundation | Q67263608 | ||
Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial | Q72528476 | ||
Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts | Q72766193 | ||
Cyclosporin A in renal transplantation: a prospective randomized trial | Q72938314 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 309-315 | |
P577 | publication date | 1983-10-01 | |
P1433 | published in | Surgery, Gynecology & Obstetrics | Q26841962 |
P1476 | title | Cadaveric renal transplantation under cyclosporine-steroid therapy | |
P478 | volume | 157 |
Q34187589 | Cadaveric renal transplantation under the American organ allocation system |
Q35253608 | Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants |
Q70318562 | Cyclosporine. Kidney transplantation |
Q45748914 | Experience with 247 living related donor nephrectomy cases at a single institution in Japan |
Q70386814 | Experience with cyclosporine and steroids in clinical renal transplantation |
Q33993337 | Factors in the Development of Liver Transplantation. |
Q34286455 | Immunosuppression and other nonsurgical factors in the improved results of liver transplantation |
Q34275290 | Liver transplantation in the ciclosporin era. |
Q44131620 | Living related kidney donors. A 14-year experience |
Q34396550 | Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants |
Q37939057 | Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation |
Q40880337 | Prevention of transplant rejection: current treatment guidelines and future developments |
Q70964381 | Successful steroid withdrawal half a year after kidney transplantation |
Q35600377 | Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats |
Q90496748 | Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival |
Search more.